• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ACR
Click for more information
1.59% 6.4¢

ACRUX LIMITED - Announcements

Market Cap $18.60M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is... Acrux Limited is an Australia-based specialty pharmaceutical company. The Company is engaged in developing and commercializing a pipeline of topically applied pharmaceutical products. Its products include Lidocaine and Prilocaine Cream, USP 2.5%/2.5%, Lenzetto, Evamist and Testosterone Topical Solution, 30 mg / 1.5 ml. Lidocaine and Prilocaine Cream USP (a eutectic mixture of lidocaine 2.5% and prilocaine 2.5%) is indicated as a topical anesthetic for use on normal intact skin for local analgesia and genital mucous membranes for superficial minor surgery and as pretreatment for infiltration anesthesia. Lenzetto(estradiol 1.53 mg/spray, transdermal spray, solution) is an estradiol spray for women which is used to treat moderate to severe hot flushes commonly associated with menopause. Testosterone Topical Solution is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ACR Quarterly Activities and Appendix 4C, reissued30/04/24 download Created with Sketch. 410.48KB
ACR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE30/04/24 download Created with Sketch. 417.11KB
ACR Launch of Dapsone 5%, Gel in the United StatesPRICE SENSITIVE03/04/24 download Created with Sketch. 73.21KB
ACR Appendix 3Y Dobinson05/03/24 download Created with Sketch. 167.86KB
ACR Appendix 3Y Brumley05/03/24 download Created with Sketch. 211.46KB
ACR Application for quotation of securities - ACR05/03/24 download Created with Sketch. 14.25KB
ACR Investor Presentation Half Year AccountsPRICE SENSITIVE27/02/24 download Created with Sketch. 699.42KB
ACR Appendix 4D and Half Year AccountsPRICE SENSITIVE27/02/24 download Created with Sketch. 687.06KB
ACR Investor Webinar Details - Financial Results 1H FY2423/02/24 download Created with Sketch. 122.61KB
ACR Application for quotation of securities - ACR14/02/24 download Created with Sketch. 16.47KB
ACR Notification regarding unquoted securities - ACR14/02/24 download Created with Sketch. 15.63KB
ACR Appendix 4C and Activities StatementPRICE SENSITIVE31/01/24 download Created with Sketch. 223.05KB
ACR Appendix 3Y Oldham20/12/23 download Created with Sketch. 211.89KB
ACR Appendix 3Y Brooke20/12/23 download Created with Sketch. 183.33KB
ACR Application for quotation of securities - ACR20/12/23 download Created with Sketch. 24.27KB
ACR Appendix 3Y Oldham05/12/23 download Created with Sketch. 212.01KB
ACR Appendix 3Y Dobinson05/12/23 download Created with Sketch. 168.3KB
ACR Appendix 3Y Brumley05/12/23 download Created with Sketch. 210.8KB
ACR Appendix 3Y Brooke05/12/23 download Created with Sketch. 202.21KB
ACR Notification regarding unquoted securities - ACR05/12/23 download Created with Sketch. 25.98KB
ACR Results of AGM29/11/23 download Created with Sketch. 129.09KB
ACR Address of Chair and CEO to AGMPRICE SENSITIVE29/11/23 download Created with Sketch. 890.47KB
ACR Appendix 3Y Dobinson24/11/23 download Created with Sketch. 195.94KB
ACR Appendix 3Y Brumley24/11/23 download Created with Sketch. 210.57KB
ACR Application for quotation of securities - ACR24/11/23 download Created with Sketch. 24.27KB
ACR Notification of cessation of securities - ACR24/11/23 download Created with Sketch. 21.51KB
ACR Acrux receives $2.88m R&D Tax Incentive Rebate for FY23PRICE SENSITIVE08/11/23 download Created with Sketch. 114.91KB
ACR Notice of Annual General Meeting/Proxy Form27/10/23 download Created with Sketch. 614.75KB
ACR Appendix 4C and Activities StatementPRICE SENSITIVE27/10/23 download Created with Sketch. 212.15KB
ACR Acrux and Dash mutually terminate commercial agreement19/09/23 download Created with Sketch. 40.78KB
ACR Appendix 3Y Brooke30/08/23 download Created with Sketch. 212.69KB
ACR Appendix 3Y Dobinson30/08/23 download Created with Sketch. 196.34KB
ACR Appendix 3Y Brumley30/08/23 download Created with Sketch. 211.35KB
ACR Application for quotation of securities - ACR30/08/23 download Created with Sketch. 26.41KB
ACR FY23 Results Webinar25/08/23 download Created with Sketch. 119.66KB
ACR Investor Presentation - Acrux FY23 ResultsPRICE SENSITIVE25/08/23 download Created with Sketch. 620.84KB
ACR Appendix 4G and Corporate Governance Statement25/08/23 download Created with Sketch. 476.19KB
ACR Appendix 4E and FY23 Annual ReportPRICE SENSITIVE25/08/23 download Created with Sketch. 10.71MB
ACR Activities Statement and Appendix 4CPRICE SENSITIVE27/07/23 download Created with Sketch. 219.09KB
ACR Acrux's seventh generic dossier accepted by FDA for reviewPRICE SENSITIVE04/07/23 download Created with Sketch. 136.02KB
ACR Appendix 3Y Brooke16/06/23 download Created with Sketch. 212.72KB
ACR Application for quotation of securities - ACR16/06/23 download Created with Sketch. 26.24KB
ACR 4th FDA ANDA approval received - Dapsone Gel, 5%PRICE SENSITIVE07/06/23 download Created with Sketch. 149.43KB
ACR Appendix 3Y Dobinson24/05/23 download Created with Sketch. 195.84KB
ACR Appendix 3Y Brumley24/05/23 download Created with Sketch. 211.28KB
ACR Application for quotation of securities - ACR24/05/23 download Created with Sketch. 26.24KB
ACR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE26/04/23 download Created with Sketch. 208.11KB
ACR Appendix 3Y Oldham31/03/23 download Created with Sketch. 211.93KB
ACR Appendix 3Y Brooke31/03/23 download Created with Sketch. 212.58KB
ACR Application for quotation of securities - ACR31/03/23 download Created with Sketch. 26.24KB
ACR Notification of cessation of securities - ACR31/03/23 download Created with Sketch. 21.57KB
ACR Appendix 3Y Buumley09/03/23 download Created with Sketch. 211.34KB
ACR Appendix 3Y Dobinson01/03/23 download Created with Sketch. 196.2KB
ACR Appendix 3Y Brumley01/03/23 download Created with Sketch. 211.16KB
ACR Application for quotation of securities - ACR01/03/23 download Created with Sketch. 26.24KB
ACR Appendix 4D and Half Year ReportPRICE SENSITIVE23/02/23 download Created with Sketch. 642.71KB
ACR Notification regarding unquoted securities - ACR13/02/23 download Created with Sketch. 25.89KB
ACR Application for quotation of securities - ACR13/02/23 download Created with Sketch. 25.73KB
ACR Quarterly Activities / Appendix 4C Cashflow ReportPRICE SENSITIVE30/01/23 download Created with Sketch. 324.06KB
ACR Gedeon Richter buyout Lenzetto Royalties for EUR4.1millionPRICE SENSITIVE23/01/23 download Created with Sketch. 76.86KB
ACR Positive FDA Remote Regulatory Assessment19/01/23 download Created with Sketch. 132.77KB
ACR Launch of prilocaine and lidocaine cream in United StatesPRICE SENSITIVE21/12/22 download Created with Sketch. 169.98KB
ACR Mutual Termination of Co-Development AgreementPRICE SENSITIVE15/12/22 download Created with Sketch. 40.8KB
ACR Appendix 3Y - Brooke01/12/22 download Created with Sketch. 212.43KB
ACR Appendix 3Y - Dobinson01/12/22 download Created with Sketch. 195.58KB
ACR Appendix 3Y - Brumley01/12/22 download Created with Sketch. 211.09KB
ACR Application for quotation of securities - ACR01/12/22 download Created with Sketch. 26.41KB
ACR Appendix 3Y Dobinson25/11/22 download Created with Sketch. 196.15KB
ACR Appendix 3Y Brooke25/11/22 download Created with Sketch. 212.69KB
ACR Appendix 3Y Oldham25/11/22 download Created with Sketch. 212.11KB
ACR Appendix 3Y Brumley25/11/22 download Created with Sketch. 211.28KB
ACR Notification regarding unquoted securities - ACR25/11/22 download Created with Sketch. 25.99KB
ACR Results of AGM23/11/22 download Created with Sketch. 194.76KB
ACR Chairman and CEO address to AGMPRICE SENSITIVE23/11/22 download Created with Sketch. 889.08KB
ACR Final FY22 R&D Tax Incentive balance received (OSF)03/11/22 download Created with Sketch. 115.69KB
ACR Appendix 3Y Geoff Brooke28/10/22 download Created with Sketch. 212.11KB
ACR Appendix 3Y Ross Dobinson28/10/22 download Created with Sketch. 195.52KB
ACR Application for quotation of securities - ACR28/10/22 download Created with Sketch. 26.24KB
ACR Quarterly Activities/Appendix 4C Cash Flow ReportPRICE SENSITIVE28/10/22 download Created with Sketch. 246.12KB
ACR R&D Tax Incentive receipt - Overseas Finding27/10/22 download Created with Sketch. 114.76KB
ACR Notice of Annual General Meeting/Proxy Form21/10/22 download Created with Sketch. 576.13KB
ACR Application for quotation of securities - ACR17/10/22 download Created with Sketch. 25.76KB
ACR Remaining balance of R&D Tax Incentive Rebate receivedPRICE SENSITIVE03/10/22 download Created with Sketch. 115.41KB
ACR R&D Tax Incentive Rebate received26/09/22 download Created with Sketch. 40.49KB
ACR Notification of cessation of securities - ACR30/08/22 download Created with Sketch. 21.56KB
ACR Appendix 3Y - Brumley30/08/22 download Created with Sketch. 254.72KB
ACR Application for quotation of securities - ACR30/08/22 download Created with Sketch. 26.11KB
ACR Appendix 4G and Corporate Governance Statement26/08/22 download Created with Sketch. 497.87KB
ACR Appendix 4E and FY22 Annual ReportPRICE SENSITIVE26/08/22 download Created with Sketch. 7.47MB
ACR Acrux's sixth generic dossier accepted by FDA for reviewPRICE SENSITIVE08/08/22 download Created with Sketch. 153.25KB
ACR Updated Corporate Policy - Code of Conduct28/06/22 download Created with Sketch. 202.78KB
ACR Appendix 3Y - Oldham22/06/22 download Created with Sketch. 255.84KB
ACR Application for quotation of securities - ACR22/06/22 download Created with Sketch. 26.16KB
ACR Acrux announces commercial agreement with PadagisPRICE SENSITIVE20/06/22 download Created with Sketch. 149.19KB
ACR Successful patent litigation outcomePRICE SENSITIVE30/05/22 download Created with Sketch. 172.29KB
ACR Appendix 3Y - Brumley23/05/22 download Created with Sketch. 254.67KB
ACR Appendix 3Y - Dobinson23/05/22 download Created with Sketch. 213.75KB
ACR Application for quotation of securities - ACR23/05/22 download Created with Sketch. 26.14KB
ACR Notification of cessation of securities - ACR14/04/22 download Created with Sketch. 21.43KB
ACR Application for quotation of securities - ACR14/04/22 download Created with Sketch. 25.75KB
ACR Quarterly Activities and Appendix 4C, reissued
30/04/24 download Created with Sketch. 410.48KB
ACR Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24PRICE SENSITIVE download Created with Sketch. 417.11KB
ACR Launch of Dapsone 5%, Gel in the United States
03/04/24PRICE SENSITIVE download Created with Sketch. 73.21KB
ACR Appendix 3Y Dobinson
05/03/24 download Created with Sketch. 167.86KB
ACR Appendix 3Y Brumley
05/03/24 download Created with Sketch. 211.46KB
ACR Application for quotation of securities - ACR
05/03/24 download Created with Sketch. 14.25KB
ACR Investor Presentation Half Year Accounts
27/02/24PRICE SENSITIVE download Created with Sketch. 699.42KB
ACR Appendix 4D and Half Year Accounts
27/02/24PRICE SENSITIVE download Created with Sketch. 687.06KB
ACR Investor Webinar Details - Financial Results 1H FY24
23/02/24 download Created with Sketch. 122.61KB
ACR Application for quotation of securities - ACR
14/02/24 download Created with Sketch. 16.47KB
ACR Notification regarding unquoted securities - ACR
14/02/24 download Created with Sketch. 15.63KB
ACR Appendix 4C and Activities Statement
31/01/24PRICE SENSITIVE download Created with Sketch. 223.05KB
ACR Appendix 3Y Oldham
20/12/23 download Created with Sketch. 211.89KB
ACR Appendix 3Y Brooke
20/12/23 download Created with Sketch. 183.33KB
ACR Application for quotation of securities - ACR
20/12/23 download Created with Sketch. 24.27KB
ACR Appendix 3Y Oldham
05/12/23 download Created with Sketch. 212.01KB
ACR Appendix 3Y Dobinson
05/12/23 download Created with Sketch. 168.3KB
ACR Appendix 3Y Brumley
05/12/23 download Created with Sketch. 210.8KB
ACR Appendix 3Y Brooke
05/12/23 download Created with Sketch. 202.21KB
ACR Notification regarding unquoted securities - ACR
05/12/23 download Created with Sketch. 25.98KB
ACR Results of AGM
29/11/23 download Created with Sketch. 129.09KB
ACR Address of Chair and CEO to AGM
29/11/23PRICE SENSITIVE download Created with Sketch. 890.47KB
ACR Appendix 3Y Dobinson
24/11/23 download Created with Sketch. 195.94KB
ACR Appendix 3Y Brumley
24/11/23 download Created with Sketch. 210.57KB
ACR Application for quotation of securities - ACR
24/11/23 download Created with Sketch. 24.27KB
ACR Notification of cessation of securities - ACR
24/11/23 download Created with Sketch. 21.51KB
ACR Acrux receives $2.88m R&D Tax Incentive Rebate for FY23
08/11/23PRICE SENSITIVE download Created with Sketch. 114.91KB
ACR Notice of Annual General Meeting/Proxy Form
27/10/23 download Created with Sketch. 614.75KB
ACR Appendix 4C and Activities Statement
27/10/23PRICE SENSITIVE download Created with Sketch. 212.15KB
ACR Acrux and Dash mutually terminate commercial agreement
19/09/23 download Created with Sketch. 40.78KB
ACR Appendix 3Y Brooke
30/08/23 download Created with Sketch. 212.69KB
ACR Appendix 3Y Dobinson
30/08/23 download Created with Sketch. 196.34KB
ACR Appendix 3Y Brumley
30/08/23 download Created with Sketch. 211.35KB
ACR Application for quotation of securities - ACR
30/08/23 download Created with Sketch. 26.41KB
ACR FY23 Results Webinar
25/08/23 download Created with Sketch. 119.66KB
ACR Investor Presentation - Acrux FY23 Results
25/08/23PRICE SENSITIVE download Created with Sketch. 620.84KB
ACR Appendix 4G and Corporate Governance Statement
25/08/23 download Created with Sketch. 476.19KB
ACR Appendix 4E and FY23 Annual Report
25/08/23PRICE SENSITIVE download Created with Sketch. 10.71MB
ACR Activities Statement and Appendix 4C
27/07/23PRICE SENSITIVE download Created with Sketch. 219.09KB
ACR Acrux's seventh generic dossier accepted by FDA for review
04/07/23PRICE SENSITIVE download Created with Sketch. 136.02KB
ACR Appendix 3Y Brooke
16/06/23 download Created with Sketch. 212.72KB
ACR Application for quotation of securities - ACR
16/06/23 download Created with Sketch. 26.24KB
ACR 4th FDA ANDA approval received - Dapsone Gel, 5%
07/06/23PRICE SENSITIVE download Created with Sketch. 149.43KB
ACR Appendix 3Y Dobinson
24/05/23 download Created with Sketch. 195.84KB
ACR Appendix 3Y Brumley
24/05/23 download Created with Sketch. 211.28KB
ACR Application for quotation of securities - ACR
24/05/23 download Created with Sketch. 26.24KB
ACR Quarterly Activities/Appendix 4C Cash Flow Report
26/04/23PRICE SENSITIVE download Created with Sketch. 208.11KB
ACR Appendix 3Y Oldham
31/03/23 download Created with Sketch. 211.93KB
ACR Appendix 3Y Brooke
31/03/23 download Created with Sketch. 212.58KB
ACR Application for quotation of securities - ACR
31/03/23 download Created with Sketch. 26.24KB
ACR Notification of cessation of securities - ACR
31/03/23 download Created with Sketch. 21.57KB
ACR Appendix 3Y Buumley
09/03/23 download Created with Sketch. 211.34KB
ACR Appendix 3Y Dobinson
01/03/23 download Created with Sketch. 196.2KB
ACR Appendix 3Y Brumley
01/03/23 download Created with Sketch. 211.16KB
ACR Application for quotation of securities - ACR
01/03/23 download Created with Sketch. 26.24KB
ACR Appendix 4D and Half Year Report
23/02/23PRICE SENSITIVE download Created with Sketch. 642.71KB
ACR Notification regarding unquoted securities - ACR
13/02/23 download Created with Sketch. 25.89KB
ACR Application for quotation of securities - ACR
13/02/23 download Created with Sketch. 25.73KB
ACR Quarterly Activities / Appendix 4C Cashflow Report
30/01/23PRICE SENSITIVE download Created with Sketch. 324.06KB
ACR Gedeon Richter buyout Lenzetto Royalties for EUR4.1million
23/01/23PRICE SENSITIVE download Created with Sketch. 76.86KB
ACR Positive FDA Remote Regulatory Assessment
19/01/23 download Created with Sketch. 132.77KB
ACR Launch of prilocaine and lidocaine cream in United States
21/12/22PRICE SENSITIVE download Created with Sketch. 169.98KB
ACR Mutual Termination of Co-Development Agreement
15/12/22PRICE SENSITIVE download Created with Sketch. 40.8KB
ACR Appendix 3Y - Brooke
01/12/22 download Created with Sketch. 212.43KB
ACR Appendix 3Y - Dobinson
01/12/22 download Created with Sketch. 195.58KB
ACR Appendix 3Y - Brumley
01/12/22 download Created with Sketch. 211.09KB
ACR Application for quotation of securities - ACR
01/12/22 download Created with Sketch. 26.41KB
ACR Appendix 3Y Dobinson
25/11/22 download Created with Sketch. 196.15KB
ACR Appendix 3Y Brooke
25/11/22 download Created with Sketch. 212.69KB
ACR Appendix 3Y Oldham
25/11/22 download Created with Sketch. 212.11KB
ACR Appendix 3Y Brumley
25/11/22 download Created with Sketch. 211.28KB
ACR Notification regarding unquoted securities - ACR
25/11/22 download Created with Sketch. 25.99KB
ACR Results of AGM
23/11/22 download Created with Sketch. 194.76KB
ACR Chairman and CEO address to AGM
23/11/22PRICE SENSITIVE download Created with Sketch. 889.08KB
ACR Final FY22 R&D Tax Incentive balance received (OSF)
03/11/22 download Created with Sketch. 115.69KB
ACR Appendix 3Y Geoff Brooke
28/10/22 download Created with Sketch. 212.11KB
ACR Appendix 3Y Ross Dobinson
28/10/22 download Created with Sketch. 195.52KB
ACR Application for quotation of securities - ACR
28/10/22 download Created with Sketch. 26.24KB
ACR Quarterly Activities/Appendix 4C Cash Flow Report
28/10/22PRICE SENSITIVE download Created with Sketch. 246.12KB
ACR R&D Tax Incentive receipt - Overseas Finding
27/10/22 download Created with Sketch. 114.76KB
ACR Notice of Annual General Meeting/Proxy Form
21/10/22 download Created with Sketch. 576.13KB
ACR Application for quotation of securities - ACR
17/10/22 download Created with Sketch. 25.76KB
ACR Remaining balance of R&D Tax Incentive Rebate received
03/10/22PRICE SENSITIVE download Created with Sketch. 115.41KB
ACR R&D Tax Incentive Rebate received
26/09/22 download Created with Sketch. 40.49KB
ACR Notification of cessation of securities - ACR
30/08/22 download Created with Sketch. 21.56KB
ACR Appendix 3Y - Brumley
30/08/22 download Created with Sketch. 254.72KB
ACR Application for quotation of securities - ACR
30/08/22 download Created with Sketch. 26.11KB
ACR Appendix 4G and Corporate Governance Statement
26/08/22 download Created with Sketch. 497.87KB
ACR Appendix 4E and FY22 Annual Report
26/08/22PRICE SENSITIVE download Created with Sketch. 7.47MB
ACR Acrux's sixth generic dossier accepted by FDA for review
08/08/22PRICE SENSITIVE download Created with Sketch. 153.25KB
ACR Updated Corporate Policy - Code of Conduct
28/06/22 download Created with Sketch. 202.78KB
ACR Appendix 3Y - Oldham
22/06/22 download Created with Sketch. 255.84KB
ACR Application for quotation of securities - ACR
22/06/22 download Created with Sketch. 26.16KB
ACR Acrux announces commercial agreement with Padagis
20/06/22PRICE SENSITIVE download Created with Sketch. 149.19KB
ACR Successful patent litigation outcome
30/05/22PRICE SENSITIVE download Created with Sketch. 172.29KB
ACR Appendix 3Y - Brumley
23/05/22 download Created with Sketch. 254.67KB
ACR Appendix 3Y - Dobinson
23/05/22 download Created with Sketch. 213.75KB
ACR Application for quotation of securities - ACR
23/05/22 download Created with Sketch. 26.14KB
ACR Notification of cessation of securities - ACR
14/04/22 download Created with Sketch. 21.43KB
ACR Application for quotation of securities - ACR
14/04/22 download Created with Sketch. 25.75KB
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
6.4¢ 		Change
0.001(1.59%) 		Mkt cap ! $18.60M
Open High Low Value Volume
6.4¢ 6.6¢ 6.3¢ $27.96K 432.3K

Buyers (Bids)

No. Vol. Price($)
1 3828 6.3¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 214977 1
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
6.3¢ 		  Change
0.001 ( 0.00 %)
Open High Low Volume
6.5¢ 6.7¢ 6.3¢ 79044
Last updated 15.56pm 10/05/2024 ?
ACR (ASX) Chart

Top Stories

Prominence impresses the market with uranium grading 5,269ppm in Kazakhstan

Prominence Energy has seen shares rise 33% on news of uranium grading up to 5,269ppm from early sampling work in Kazakhstan.
Raiden opens door to private Mallina in win-win Arrow Gold divestment Raiden Resources has announced its execution of a farm-in deal on-site Raiden's non-core asset, the Arrow gold project.
Recce breathes better on positive lung infection drug pilot test results Recce Pharmaceuticals Ltd has revealed positive results from its pilot test on synthetic drug Recce 327, which aims to treat lung infections.
UNITH's digital humans expand into Amazon; Facebook AI-powered 'Digital Human' chatbot developer UNITH has announced its in-house tech can now harmonise with that used by Facebook and Amazon.
CBA profits fall 3% in March quarter but funding portfolio is flourishing Commonwealth Bank has reported a 3 percent fall in profits for the March quarter of 2024, compared to the previous quarter.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.